Authors
Loading...
Randomized trial demonstrates selective targeting of ovarian cancer tumors using engineered extracellular vesicles, indicating a promising approach for treatment.
Godbole et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: